Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Octreotide injection		Amber - palliative care use only Red - Oncology, acromegaly
Ofatumumab	TA344 - Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia	For hospital use only
Ofatumumab (Kesimpta®)	TA699 - Ofatumumab for treating relapsing multiple sclerosis
Oily phenol
Olaratumab	TA465 - Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma	For hospital use only
Omalizumab	TA339 - Omalizumab for previously treated chronic spontaneous urticaria TA278 - Omalizumab for treating severe persistent allergic asthma	Hospital only
Omalizumab	TA339 - Omalizumab for previously treated chronic spontaneous urticaria
Omeprazole IV		Hospital use only
Ondansetron injection		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only
Ondansetron melt tablets		Red for chemotherapy Amber for hyperemesis in pregnancy (off label) Amber for palliative care (off label) Syrup - swallowing difficulties only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.